- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 3.20 Å
- Oligo State
- hetero-3-3-3-3-3-3-mer
- Ligands
- 11 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN.7: 11 residues within 4Å:- Chain A: E.280, N.281, T.283
- Chain H: N.26, G.27, Y.28, R.62, W.63, G.64, Y.67, Y.87
1 PLIP interactions:1 interactions with chain H- Hydrophobic interactions: H:Y.28
- Hydrogen bonds: H:R.62, H:R.62, H:G.64, H:G.64
NAG-NAG-BMA-MAN.19: 13 residues within 4Å:- Chain F: S.214, E.216, P.217, K.257, V.259, L.266, N.267, N.381, R.447, C.448, V.449, S.450
- Ligands: NAG.53
1 PLIP interactions:1 interactions with chain F- Hydrophobic interactions: F:V.449
- Hydrogen bonds: F:S.214
- 4 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN.8: 13 residues within 4Å:- Chain A: N.142
- Chain I: Y.33, G.55, D.56, T.57, N.58, H.100, R.102, F.114, T.115
- Chain J: W.86, D.87, T.92
2 PLIP interactions:2 interactions with chain I- Hydrogen bonds: I:N.58, I:T.115, I:T.115, I:T.57, I:N.58
NAG-NAG-BMA-MAN-MAN.14: 8 residues within 4Å:- Chain E: D.146, N.367, S.368, T.376, N.390, S.392
- Ligands: NAG-NAG.15, NAG-NAG.15
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN.17: 12 residues within 4Å:- Chain E: N.142, I.143
- Chain M: Y.33, D.56, N.58, R.102, F.114
- Chain N: W.86, D.87, S.88, R.90, T.92
2 PLIP interactions:2 interactions with chain M- Hydrogen bonds: M:N.58, M:T.115
NAG-NAG-BMA-MAN-MAN.26: 14 residues within 4Å:- Chain F: N.142
- Chain Q: Y.33, Y.50, H.52, G.55, D.56, T.57, H.100, F.114, T.115
- Chain R: W.86, D.87, R.90, T.92
2 PLIP interactions:2 interactions with chain Q- Hydrogen bonds: Q:Y.50, Q:D.56, Q:Y.33, Q:H.52
- 4 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.11: 10 residues within 4Å:- Chain E: E.216, P.217, V.259, L.266, N.267, N.381, G.383, V.449, S.450
- Ligands: NAG-NAG.16
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:V.449
NAG-NAG-BMA.12: 6 residues within 4Å:- Chain E: E.280, N.281
- Chain L: G.27, Y.28, R.62, Y.87
1 PLIP interactions:1 interactions with chain L- Hydrophobic interactions: L:Y.28
- Hydrogen bonds: L:R.62, L:G.64
NAG-NAG-BMA.20: 9 residues within 4Å:- Chain F: E.280, N.281
- Chain P: G.27, Y.28, R.62, Q.65, Y.67, Y.87
- Ligands: NAG.50
1 PLIP interactions:1 interactions with chain P- Hydrophobic interactions: P:Y.28
- Hydrogen bonds: P:R.62, P:Q.65
NAG-NAG-BMA.24: 6 residues within 4Å:- Chain F: N.367, S.368, T.376, N.390
- Ligands: NAG-NAG.25, NAG-NAG.25
No protein-ligand interaction detected (PLIP)- 2 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN-MAN-MAN.13: 15 residues within 4Å:- Chain E: T.302, H.334, N.336
- Chain M: R.103, I.104, G.106, V.107, V.108
- Chain N: S.22, N.42, N.43, N.44, P.58, G.59, S.60
1 PLIP interactions:1 interactions with chain M- Hydrogen bonds: M:G.106, M:V.108, M:R.103
NAG-NAG-BMA-MAN-MAN-MAN-MAN.23: 17 residues within 4Å:- Chain F: N.300, T.302, R.331, H.334, N.336, R.447
- Chain Q: R.103, I.104, G.106, V.107, V.108
- Chain R: S.22, N.42, N.43, N.44, G.59, S.60
1 PLIP interactions:1 interactions with chain Q- Hydrogen bonds: Q:G.106, Q:V.108, Q:R.103
- 1 x NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 28 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.27: 4 residues within 4Å:- Chain A: E.92, N.93
- Chain D: G.13, S.17
Ligand excluded by PLIPNAG.28: 1 residues within 4Å:- Chain A: N.138
Ligand excluded by PLIPNAG.29: 5 residues within 4Å:- Chain A: T.133, Q.135, S.155, F.156, N.157
Ligand excluded by PLIPNAG.30: 3 residues within 4Å:- Chain A: N.239, T.241, G.242
Ligand excluded by PLIPNAG.31: 5 residues within 4Å:- Chain A: Q.298, N.300, R.447, V.449
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN.4
Ligand excluded by PLIPNAG.32: 2 residues within 4Å:- Chain A: N.306, V.445
Ligand excluded by PLIPNAG.33: 2 residues within 4Å:- Chain A: N.343, W.399
Ligand excluded by PLIPNAG.34: 5 residues within 4Å:- Chain A: S.392, N.396
- Ligands: NAG-NAG.5, NAG-NAG.6, NAG-NAG.6
Ligand excluded by PLIPNAG.35: 6 residues within 4Å:- Chain A: N.267, L.270, P.296, V.449, N.451
- Ligands: NAG-NAG-BMA-MAN.3
Ligand excluded by PLIPNAG.36: 4 residues within 4Å:- Chain B: K.121, S.124, N.125, Y.126
Ligand excluded by PLIPNAG.37: 2 residues within 4Å:- Chain C: N.125, Y.126
Ligand excluded by PLIPNAG.38: 5 residues within 4Å:- Chain D: K.121, E.122, I.123, S.124, N.125
Ligand excluded by PLIPNAG.39: 3 residues within 4Å:- Chain B: S.17
- Chain E: E.92, N.93
Ligand excluded by PLIPNAG.40: 7 residues within 4Å:- Chain E: C.136, N.138, R.148, K.152, N.193, K.194, Y.196
Ligand excluded by PLIPNAG.41: 6 residues within 4Å:- Chain E: T.133, Q.135, S.155, F.156, N.157, K.168
Ligand excluded by PLIPNAG.42: 6 residues within 4Å:- Chain E: D.235, K.237, F.238, N.239, T.241, P.243
Ligand excluded by PLIPNAG.43: 7 residues within 4Å:- Chain E: Q.298, N.300, N.336, V.337, S.338, S.416, R.447
Ligand excluded by PLIPNAG.44: 3 residues within 4Å:- Chain E: N.306, I.327, V.445
Ligand excluded by PLIPNAG.45: 2 residues within 4Å:- Chain E: N.343, W.399
Ligand excluded by PLIPNAG.46: 3 residues within 4Å:- Chain E: S.392, N.396
- Ligands: NAG-NAG.15
Ligand excluded by PLIPNAG.47: 3 residues within 4Å:- Chain F: N.138, R.148, G.149
Ligand excluded by PLIPNAG.48: 5 residues within 4Å:- Chain F: Q.135, S.155, F.156, N.157, K.168
Ligand excluded by PLIPNAG.49: 7 residues within 4Å:- Chain F: V.179, R.197, N.202, T.203
- Chain O: H.73, A.74, W.76
Ligand excluded by PLIPNAG.50: 3 residues within 4Å:- Chain F: N.239, T.241
- Ligands: NAG-NAG-BMA.20
Ligand excluded by PLIPNAG.51: 3 residues within 4Å:- Chain F: N.343, E.344, W.399
Ligand excluded by PLIPNAG.52: 5 residues within 4Å:- Chain F: S.392, G.393, N.396
- Ligands: NAG-NAG.25, NAG-NAG.25
Ligand excluded by PLIPNAG.53: 5 residues within 4Å:- Chain F: L.270, P.296, V.449, N.451
- Ligands: NAG-NAG-BMA-MAN.19
Ligand excluded by PLIPNAG.54: 4 residues within 4Å:- Chain C: G.16, S.17
- Chain F: E.92, N.93
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Chaturbhuj, D.N. et al., A modification to heptad repeat 1 of gp41 improves yield and/or quality of soluble pre-fusion HIV-1 envelope glycoprotein trimers. J.Virol. (2025)
- Release Date
- 2025-08-27
- Peptides
- HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp120: AEF
Envelope glycoprotein gp160: BCD
3BNC117 Fab heavy chain: GKO
3BNC117 Fab light chain: HLP
PGT122 Fab heavy chain: IMQ
PGT122 Fab light chain: JNR - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AE
EF
CB
FC
DD
BG
HK
MO
PH
IL
LP
QI
JM
NQ
RJ
KN
OR
S
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 3.20 Å
- Oligo State
- hetero-3-3-3-3-3-3-mer
- Ligands
- 11 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 28 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Chaturbhuj, D.N. et al., A modification to heptad repeat 1 of gp41 improves yield and/or quality of soluble pre-fusion HIV-1 envelope glycoprotein trimers. J.Virol. (2025)
- Release Date
- 2025-08-27
- Peptides
- HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp120: AEF
Envelope glycoprotein gp160: BCD
3BNC117 Fab heavy chain: GKO
3BNC117 Fab light chain: HLP
PGT122 Fab heavy chain: IMQ
PGT122 Fab light chain: JNR - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AE
EF
CB
FC
DD
BG
HK
MO
PH
IL
LP
QI
JM
NQ
RJ
KN
OR
S